Hemp industry looks to Ottawa for regulation changes
OTTAWA –– Health food and hemp industry groups want Ottawa to change the regulations for C-B-D to treat the cannabinoid as a natural health product rather than a drug.
The Canadian Health Food Association and the Canadian Hemp Trade Alliance say C-B-D, a non-intoxicating compound which can be derived from cannabis and hemp, should be removed from the prescription drug list.
The groups also want a regulatory pathway to allow for C-B-D derived from industrial hemp to be included in natural health products and supplemented foods.